EGFR is an important glycoprotein for cancer biology with a significant number of glycosylation sites (7–13 N-glycosylations in the extracellular domain); it is highly expressed in different cancers and is considered a proteomic marker [76,77,78,79]. The gene discussed is EGFR; the disease is cancer.